Technologies for sampling abnormal cells in the oesophagus

NHS England is initiating a procurement process titled "Technologies for sampling abnormal cells in the oesophagus." This tender falls under the industry category of diagnostic devices and medical equipment, with a focus on goods and services. It is based in London, United Kingdom, at Wellington House, 133-135 Waterloo Road.

Currently, the process is in the planning stage, and the preliminary market consultation is scheduled to take place by 17th November 2025. This consultation aims to garner insights to shape the NHS's commercial strategy for this project. Key legal frameworks include UKPGA 2023/54, and future notices are anticipated by 1st April 2027, with the contracting period expected to run from 1st July 2027 to 30th June 2028.

This procurement opportunity presents significant growth potential for businesses involved in the development and supply of diagnostic equipment and medical consumables. Small and medium-sized enterprises (SMEs) as well as voluntary community and social enterprises (VCSEs) are especially encouraged to participate, given the contract's suitability for these demographics. Companies that specialise in pathology services, diagnostic supplies, and medical devices will find this tender particularly relevant.

Interested parties should register on the Atamis e-sourcing portal to express interest and participate in the tender process, positioning themselves for future collaboration with NHS England.